Alexion Pharmaceuticals has announced that it will acquire Swedish biopharmaceutical company Wilson Therapeutics for $855m. Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in […]
Otsuka Pharmaceutical has entered an agreement with Takara Bio for the co-development and exclusive sales rights in Japan for two of Takara’s gene therapy products. Takara will receive upfront and milestone payments from Otsuka of […]
AstraZeneca has licensed a fatty liver disease treatment IONIS-AZ6-2.5-LRx (AZD2693) from Ionis Pharmaceuticals in a deal that could fetch up to $300m for the California firm in milestone payments. IONIS-AZ6-2.5-LRx has been designed by the […]
Constellation Pharmaceuticals, a clinical-stage biopharmaceutical company developing tumor-targeted and immuno-oncology therapies, has raised a $100m financing. New investors include Cormorant Asset Management, Deerfield Management, Fidelity Management and Research Company, Hillhouse Capital, NS Investment, OrbiMed, Sirona […]
Pfizer joined the TriNetX global health research network, which will allow it to access clinical data from the network’s healthcare organizations. TriNetX, headquartered in Cambridge, Massachusetts, connects healthcare organizations, biopharmaceutical companies and contract research organizations (CROs) […]